glp 1 analoga präparate Swissmedic warnt vor gefälschten und irreführenden «GLP-1»-Produkten zur Gewichtsreduktion Inkretin-Mimetika: Eine praxisrelevante Übersicht

Unlike psyllium husk fiber supplements that can form a thick gel or gritty texture, this soluble fiber dissolves cleanly with no clumping, making it easy to incorporate into your daily routine

In addition, Dula decreased the oxidative stress biomarker malondialdehyde (MDA) and increased the antioxidant enzymes (total antioxidant capacity (TAC), reduced glutathione (GSH), and superoxide dismutase (SOD) concentrations)

How a Healthy Gut Supports Natural GLP-1 Productionand Why Probiotics Matter In recent years, GLP-1 has become a buzzword in health and wellness circlesand for good reason

Find out how to join today.

Roberts C, et al

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications